Fermenta Biotech informs about updates

10 Dec 2025 Evaluate

Fermenta Biotech has informed that the Board of Directors of the Company, at its meeting held today on December 10, 2025, has approved capacity addition requiring investment of up to Rs 110 crores at its existing facility in Dahej, Gujarat, for production of Plant based Vitamin D3, Vitamin D3 derivatives, and Green Chemistry Enzymes to be phased across FY26 and FY27. The information required as per Listing Regulations read with SEBI Master Circular no. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024 (‘Master Circular’) is enclosed as Annexure A. Press release explaining the rationale and other information related to capacity addition is also enclosed. The Board meeting commenced at 11:30 am (IST) and concluded at 2:50 pm (IST). 

The above information is a part of company’s filings submitted to BSE.

Fermenta Biotech Share Price

350.70 -0.45 (-0.13%)
16-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1782.80
Dr. Reddys Lab 1279.00
Cipla 1500.00
Zydus Lifesciences 913.90
Lupin 2089.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×